Capital expenditure · 2011–2025
PTC Therapeutics capital expenditure
$8.9M+36.3% · FY2025
PTC Therapeutics (PTCT) reported $8.9M in capital expenditure for fiscal 2025, +36.3% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $8.9M | +36.3% | Open → |
| FY20242024-12-31 | $6.5M | −77.1% | Open → |
| FY20232023-12-31 | $28.4M | −11.2% | Open → |
| FY20222022-12-31 | $32.0M | +13.5% | Open → |
| FY20212021-12-31 | $28.2M | +58.1% | Open → |
| FY20202020-12-31 | $17.8M | +29.7% | Open → |
| FY20192019-12-31 | $13.8M | +93.8% | Open → |
| FY20182018-12-31 | $7.1M | +128.9% | Open → |
| FY20172017-12-31 | $3.1M | +74.6% | Open → |
| FY20162016-12-31 | $1.8M | −34.7% | Open → |
| FY20152015-12-31 | $2.7M | −41.7% | Open → |
| FY20142014-12-31 | $4.7M | +451.3% | Open → |
| FY20132013-12-31 | $846,000 | +347.6% | Open → |
| FY20122012-12-31 | $189,000 | +14.5% | Open → |
| FY20112011-12-31 | $165,116 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +32.9%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=PTC Therapeutics capital expenditure |url=https://companiesranked.com/en/company/ptc-therapeutics/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). PTC Therapeutics capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/ptc-therapeutics/capital-expenditureBibTeX
@misc{companiesranked-en-company-ptc-therapeutics-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{PTC Therapeutics capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ptc-therapeutics/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001104659-26-017575 · February 19, 2026
{{cite web |title=PTC Therapeutics capital expenditure — 10-K (0001104659-26-017575) |url=https://www.sec.gov/Archives/edgar/data/1070081/000110465926017575/tmb-20251231x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-19}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.